Explore more publications!

Technology News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.

Press releases published on December 11, 2025

Lesaka Webcast and Conference Call to Review Second Quarter 2026 Results
BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Netskope Announces Strong Third Quarter Fiscal Year 2026 Financial Results
Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Datavault AI Inc. (NASDAQ: DVLT) Announces a Distribution Date of Dec. 24, 2025, for the Dream Bowl Meme Coin Tokens to All Eligible Record Equity Holders of Datavault AI and Holders of Common Stock of Scilex Holding Company
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Datavault AI Inc. (NASDAQ: DVLT) Announces a Distribution Date of Dec. 24, 2025, for the Dream Bowl Meme Coin Tokens to All Eligible Record Equity Holders of Datavault AI and Holders of Common Stock of Scilex Holding Company
Ramon Sanchez Joins Firefly Aerospace as Chief Operating Officer
Frequency Electronics, Inc. Announces Second Quarter and Fiscal Year 2026 Financial Results
Tenaya Therapeutics Announces Proposed Public Offering
Oruka Therapeutics Announces New Board Member and Board Transition
Nusano Receives “Best Companies to Work For” Award from Utah Business
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Pixalate’s November 2025 LATAM SSP ‘Direct’ Access to Top 100 Mobile Apps Rankings: Google AdExchange No. 1 on Google Play Store (97%)
UX UI Exchange Unveils Exclusive Feature: “Brian Ferdinand on Mastery, Markets, and Building a Life With Intention”

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions